Patents by Inventor Xiaona Sun

Xiaona Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260259886
    Abstract: A data processing method includes performing a plurality rounds of model reasoning, including, for a current round of model reasoning among the plurality rounds of model reasoning, determining, based on preceding specific reflection information corresponding to a preceding round of model reasoning, current prompt information of the current round of model reasoning, and executing, based on the current prompt information, the current round of model reasoning using a target model to obtain a current reasoning result of the current round of model reasoning. The preceding specific reflection information is generated based on preceding process information of the preceding round of model reasoning and high-level reflection information representing cross-task reflection information generated by the target model. The method further includes determining a target reasoning result based on one or more reasoning results from at least two rounds of model reasoning among the plurality of rounds of model reasoning.
    Type: Application
    Filed: February 9, 2026
    Publication date: September 3, 2026
    Inventors: Xiaona SUN, Ming HE
  • Publication number: 20250154265
    Abstract: The present disclosure provides for antibody or antigen-binding fragment thereof that specifically binds to human cMET and multispecific antibody or antigen-binding fragment thereof, comprising a first antigen binding domain that specifically binds a first epitope of human cMET; a second antigen binding domain that specifically binds to a second epitope of human cMET; and a third antigen binding domain that specifically binds to human EGFR; wherein the first epitope is distinct from the second epitope, or wherein the first antigen binding domain does not compete with the second antigen binding domain. The present disclosure also provides for the use of the antibodies or multispecific antibodies for treating a disease, such as cancer.
    Type: Application
    Filed: November 22, 2024
    Publication date: May 15, 2025
    Applicant: BeiGene Ltd.
    Inventors: Renke Li, Xiaoyan Tang, Mengran Qian, Jie Pan, Zhao Zhao, Xi Wu, Ming Jiang, Hui Li, Xiaona Sun, Yanzhou Zhang, Mengmeng Lu, Yun Chen